Skip to Content

GSI 510 (Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg)

Generic Name: cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide

Pill imprint GSI 510 has been identified as Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg.

Genvoya is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510
Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510
Genvoya cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg GSI 510
Genvoya
Generic Name:
cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide
Imprint:
GSI 510
Strength:
cobicistat 150 mg / elvitegravir 150 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide